Table 2.
Clinical and laboratory characteristics of hospitalized patients according to outcome.
| Variables | No death (n = 64) | Death (n = 37) | p-value |
|---|---|---|---|
| Male sex (%) | 35 (54.68) | 20 (54.05) | 0.53 |
| Age (years)* | 57.07 ± 16.57 | 63.05 ± 13.97 | 0.048 |
| Arterial hypertension (%) | 30 (46.9) | 24 (64.9) | 0.124 |
| Diabetes mellitus (%) | 17 (26.6) | 17 (45.9) | 0.077 |
| CKD (%) | 5 (7.8) | 5 (13.5) | 0.56 |
| CVD (%) | 7 (10.9) | 12 (32.4) | 0.016 |
| Diuretic use (%) | 15 (23.4) | 14 (37.8) | 0.189 |
| GFR (ml/min/1.73 m2) on admission* | 96.2 ± 22.25 | 79.72 ± 23.15 | 0.006 |
| Mechanical ventilation (%) | 15 (23.4) | 32 (86.5) | <0.0001 |
| Vasoactive drugs (%) | 15 (23.4) | 32 (86.5) | <0.0001 |
| ICU admission (%) | 18 (28.1) | 34 (91.9) | <0.0001 |
| AKI (%) | 16 (25) | 34 (91.9) | <0.0001 |
| APACHE II* | 16.11 ± 4.39 | 23.61 ± 5.67 | <0.001 |
| SOFA** | 7.5 (2–9) | 11 (9–13) | <0.001 |
AKI, acute kidney injury; CKD, chronic kidney disease; CVD, cardiovascular disease; GFR, glomerular filtration rate (CKD-EPI); ICU, intensive care unit; APACHE II, Acute Physiology and Chronic Health Evaluation score; SOFA, Sequential Organ Failure Assessment score.
*
Mean ± SD;
**
median (IQR). Bold values refer to variables that had a p-value less than 0.05.